These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
794 related items for PubMed ID: 20437580
41. Immunosuppressive monoclonal antibody to CD64 from patients with long-term stable multiple sclerosis. Annunziata P, Cioni C, Cantalupo L, Di Genova G, Savellini GG, Cusi G. J Neuroimmunol; 2013 Mar 15; 256(1-2):62-70. PubMed ID: 23318105 [Abstract] [Full Text] [Related]
42. Imbalance in T-cell and cytokine profiles in patients with relapsing-remitting multiple sclerosis. Mikulkova Z, Praksova P, Stourac P, Bednarik J, Michalek J. J Neurol Sci; 2011 Jan 15; 300(1-2):135-41. PubMed ID: 20884014 [Abstract] [Full Text] [Related]
43. Distinct properties of circulating CD8+ T cells in FTY720-treated patients with multiple sclerosis. Johnson TA, Lapierre Y, Bar-Or A, Antel JP. Arch Neurol; 2010 Dec 15; 67(12):1449-55. PubMed ID: 21149809 [Abstract] [Full Text] [Related]
44. Increase in multiple sclerosis activity after assisted reproduction technology. Correale J, Farez MF, Ysrraelit MC. Ann Neurol; 2012 Nov 15; 72(5):682-94. PubMed ID: 23034952 [Abstract] [Full Text] [Related]
45. In vitro Th2 deviation of myelin-specific peripheral blood lymphocytes from patients with multiple sclerosis. Hallin E, Mellergård J, Vrethem M, Ernerudh J, Ekerfelt C. J Neuroimmunol; 2006 Feb 15; 171(1-2):156-62. PubMed ID: 16256209 [Abstract] [Full Text] [Related]
46. Cytokine mRNA profile of Epstein-Barr virus-stimulated highly differentiated T cells in multiple sclerosis: a pilot study. Jaquiéry E, Jilek S, Schluep M, Le Goff G, Garcia M, Pantaleo G, Du Pasquier RA. J Neuroimmunol; 2010 Aug 25; 225(1-2):167-70. PubMed ID: 20471696 [Abstract] [Full Text] [Related]
47. Lymphocytic bronchiolitis is associated with inadequate suppression of blood T-cell granzyme B, IFN-gamma, and TNF-alpha. Hodge G, Hodge S, Li-Liew C, Chambers D, Hopkins P, Reynolds PN, Holmes M. Transplantation; 2010 May 27; 89(10):1283-9. PubMed ID: 20559033 [Abstract] [Full Text] [Related]
48. Th1 not Th17 cells drive spontaneous MS-like disease despite a functional regulatory T cell response. Lowther DE, Chong DL, Ascough S, Ettorre A, Ingram RJ, Boyton RJ, Altmann DM. Acta Neuropathol; 2013 Oct 27; 126(4):501-15. PubMed ID: 23934116 [Abstract] [Full Text] [Related]
49. Interleukin-17-secreting T cells in neuromyelitis optica and multiple sclerosis during relapse. Wang HH, Dai YQ, Qiu W, Lu ZQ, Peng FH, Wang YG, Bao J, Li Y, Hu XQ. J Clin Neurosci; 2011 Oct 27; 18(10):1313-7. PubMed ID: 21795048 [Abstract] [Full Text] [Related]
50. Beneficial effect of co-polymer 1 on cytokine production by CD4 T cells in multiple sclerosis. Fellay B, Chofflon M, Juillard C, Paunier AM, Landis T, Roth S, Gougeon ML. Immunology; 2001 Dec 27; 104(4):383-91. PubMed ID: 11899423 [Abstract] [Full Text] [Related]
51. Dendritic cell, monocyte and T cell activation and response to glatiramer acetate in multiple sclerosis. Sellebjerg F, Hesse D, Limborg S, Lund H, Søndergaard HB, Krakauer M, Sørensen PS. Mult Scler; 2013 Feb 27; 19(2):179-87. PubMed ID: 22653658 [Abstract] [Full Text] [Related]
52. Effect of millimeter waves on cyclophosphamide induced suppression of T cell functions. Makar V, Logani M, Szabo I, Ziskin M. Bioelectromagnetics; 2003 Jul 27; 24(5):356-65. PubMed ID: 12820293 [Abstract] [Full Text] [Related]
53. Human central nervous system astrocytes support survival and activation of B cells: implications for MS pathogenesis. Touil H, Kobert A, Lebeurrier N, Rieger A, Saikali P, Lambert C, Fawaz L, Moore CS, Prat A, Gommerman J, Antel JP, Itoyama Y, Nakashima I, Bar-Or A, Canadian B Cell Team in MS. J Neuroinflammation; 2018 Apr 19; 15(1):114. PubMed ID: 29673365 [Abstract] [Full Text] [Related]
54. Increased in vitro induced CD4+ and CD8+ T cell IFN-gamma and CD4+ T cell IL-10 production in stable relapsing multiple sclerosis. Brod SA, Nelson LD, Khan M, Wolinsky JS. Int J Neurosci; 1997 Aug 19; 90(3-4):187-202. PubMed ID: 9352427 [Abstract] [Full Text] [Related]
55. Effects of natalizumab on circulating B cells, T regulatory cells and natural killer cells. Putzki N, Baranwal MK, Tettenborn B, Limmroth V, Kreuzfelder E. Eur Neurol; 2010 Aug 19; 63(5):311-7. PubMed ID: 20453514 [Abstract] [Full Text] [Related]
56. Tyrosine kinase 2 variant influences T lymphocyte polarization and multiple sclerosis susceptibility. Couturier N, Bucciarelli F, Nurtdinov RN, Debouverie M, Lebrun-Frenay C, Defer G, Moreau T, Confavreux C, Vukusic S, Cournu-Rebeix I, Goertsches RH, Zettl UK, Comabella M, Montalban X, Rieckmann P, Weber F, Müller-Myhsok B, Edan G, Fontaine B, Mars LT, Saoudi A, Oksenberg JR, Clanet M, Liblau RS, Brassat D. Brain; 2011 Mar 19; 134(Pt 3):693-703. PubMed ID: 21354972 [Abstract] [Full Text] [Related]
58. Cooperation of B cells and T cells in the pathogenesis of multiple sclerosis. Weber MS, Hemmer B. Results Probl Cell Differ; 2010 Mar 19; 51():115-26. PubMed ID: 19582406 [Abstract] [Full Text] [Related]
59. CRYAB modulates the activation of CD4+ T cells from relapsing-remitting multiple sclerosis patients. Quach QL, Metz LM, Thomas JC, Rothbard JB, Steinman L, Ousman SS. Mult Scler; 2013 Dec 19; 19(14):1867-77. PubMed ID: 23736536 [Abstract] [Full Text] [Related]
60. Impact of cladribine therapy on changes in circulating dendritic cell subsets, T cells and B cells in patients with multiple sclerosis. Mitosek-Szewczyk K, Tabarkiewicz J, Wilczynska B, Lobejko K, Berbecki J, Nastaj M, Dworzanska E, Kolodziejczyk B, Stelmasiak Z, Rolinski J. J Neurol Sci; 2013 Sep 15; 332(1-2):35-40. PubMed ID: 23835090 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]